REMS
Absorption: Administered IV only; results in complete bioavailability.
Distribution: Unknown.
Half-Life: 2.44 hr.
Contraindicated in:
Use Cautiously in:
CV: hypertension, T-wave inversion, arrhythmias, changes in heart rate, chest pain
Derm: flushing, pruritus, sweating
EENT: gagging, mydriasis
GI: diarrhea, nausea, vomiting
GU: urinary retention, albuminuria, perineal/genital burning sensation, spontaneous voiding
Hemat: hemolysis
Local: phlebitis
MS: muscle spasticity, involuntary movement, skeletal muscle hyperactivity
Neuro: apprehension, disorientation, dizziness, generalized clonus, headache, paresthesia, positive bilateral Babinskis sign, SEIZURES
Resp: bronchospasm, cough, dyspnea, hiccups, LARYNGOSPASM, rebound hypoventilation, tachypnea
Misc: fever
Drug-drug:
Respiratory Depression following Anesthesia
Drug-Induced CNS Depression
Acute Hypercapnea Secondary to COPD
Lab Test Considerations:
Toxicity and Overdose:
IV Administration: